ASX - By Stock
|
ATH |
Re:
The ape study in AAN
|
|
pivalde
|
3 |
1.0K |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Stamler's presentation in AAN
|
|
pivalde
|
1 |
489 |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
1
|
489
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Claassen in AAN
|
|
pivalde
|
2 |
749 |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
2
|
749
|
5
|
|
ASX - By Stock
|
ATH |
Claassen in AAN
|
|
pivalde
|
2 |
749 |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
2
|
749
|
4
|
|
ASX - By Stock
|
ATH |
The ape study in AAN
|
|
pivalde
|
3 |
1.0K |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
3
|
1.0K
|
5
|
|
ASX - By Stock
|
ATH |
Stamler's presentation in AAN
|
|
pivalde
|
1 |
489 |
7 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
1
|
489
|
7
|
|
ASX - By Stock
|
ATH |
Re:
iron accumulation/ cognition
|
|
pivalde
|
1 |
502 |
4 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
1
|
502
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
28K |
5 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
113
|
28K
|
5
|
|
ASX - By Stock
|
ATH |
iron accumulation/ cognition
|
|
pivalde
|
1 |
502 |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
1
|
502
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
pivalde
|
113 |
28K |
4 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
113
|
28K
|
4
|
|
ASX - By Stock
|
ATH |
A new MSA update
|
|
pivalde
|
1 |
603 |
6 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
1
|
603
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
pivalde
|
48 |
13K |
3 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
48
|
13K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
pivalde
|
48 |
13K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
48
|
13K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
pivalde
|
48 |
13K |
9 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
48
|
13K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
pivalde
|
48 |
13K |
4 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
48
|
13K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notice Under Section 708A
|
|
pivalde
|
48 |
13K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
48
|
13K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Episodic memory/ hippocampal iron, a human study
|
|
pivalde
|
9 |
2.4K |
6 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
9
|
2.4K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Episodic memory/ hippocampal iron, a human study
|
|
pivalde
|
9 |
2.4K |
5 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
9
|
2.4K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Episodic memory/ hippocampal iron, a human study
|
|
pivalde
|
9 |
2.4K |
6 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
9
|
2.4K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Episodic memory/ hippocampal iron, a human study
|
|
pivalde
|
9 |
2.4K |
4 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
9
|
2.4K
|
4
|
|
ASX - By Stock
|
ATH |
Episodic memory/ hippocampal iron, a human study
|
|
pivalde
|
9 |
2.4K |
5 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
9
|
2.4K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New Data at the AAN 2024 Annual Meeting
|
|
pivalde
|
12 |
4.5K |
10 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
12
|
4.5K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New Data at the AAN 2024 Annual Meeting
|
|
pivalde
|
12 |
4.5K |
5 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
12
|
4.5K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New Data at the AAN 2024 Annual Meeting
|
|
pivalde
|
12 |
4.5K |
12 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
12
|
4.5K
|
12
|
|
ASX - By Stock
|
ATH |
Re:
Hippocampal iron accumulation in hemorrhagic stroke/ cognition
|
|
pivalde
|
1 |
450 |
6 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1
|
450
|
6
|
|
ASX - By Stock
|
ATH |
Hippocampal iron accumulation in hemorrhagic stroke/ cognition
|
|
pivalde
|
1 |
450 |
7 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1
|
450
|
7
|
|
ASX - By Stock
|
ATH |
Prof. Bush et al : an entirely new pathophysiological role for ferroptosis in disease.
|
|
pivalde
|
0 |
349 |
7 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
0
|
349
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Retinal fundus in screening PD
|
|
pivalde
|
7 |
1.9K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
7
|
1.9K
|
1
|
|
ASX - By Stock
|
ATH |
open label study completion date 28th of Feb 2025
|
|
pivalde
|
0 |
209 |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
0
|
209
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Retinal fundus in screening PD
|
|
pivalde
|
7 |
1.9K |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Retinal fundus in screening PD
|
|
pivalde
|
7 |
1.9K |
5 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
7
|
1.9K
|
5
|
|
ASX - By Stock
|
ATH |
Retinal fundus in screening PD
|
|
pivalde
|
7 |
1.9K |
4 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
7
|
1.9K
|
4
|
|
ASX - By Stock
|
ATH |
What is https://finance.yahoo.com/quote/PRNAF
|
|
pivalde
|
0 |
231 |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
0
|
231
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Long COVID amyloidosis, could PBT2 help ????
|
|
pivalde
|
4 |
1.3K |
7 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
4
|
1.3K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Long COVID amyloidosis, could PBT2 help ????
|
|
pivalde
|
4 |
1.3K |
6 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
4
|
1.3K
|
6
|
|
ASX - By Stock
|
ATH |
Long COVID amyloidosis, could PBT2 help ????
|
|
pivalde
|
4 |
1.3K |
6 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
4
|
1.3K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Finally Moving North
|
|
pivalde
|
15 |
3.9K |
5 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.9K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Finally Moving North
|
|
pivalde
|
15 |
3.9K |
11 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.9K
|
11
|
|
ASX - By Stock
|
ATH |
Re:
Some "Hidden germ" info in Stamler's presentation ??
|
|
pivalde
|
6 |
1.6K |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
6
|
1.6K
|
4
|
|
ASX - By Stock
|
ATH |
Some "Hidden germ" info in Stamler's presentation ??
|
|
pivalde
|
6 |
1.6K |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
6
|
1.6K
|
4
|
|
ASX - By Stock
|
ATH |
Biogen to halt sales and development of controversial Alzheimer's drug Aduhelm
|
|
pivalde
|
1 |
570 |
6 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
1
|
570
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Levodopa rescues retinal function in PD model by Finkelstein et al
|
|
pivalde
|
3 |
1.3K |
7 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
3
|
1.3K
|
7
|
|
ASX - By Stock
|
ATH |
Levodopa rescues retinal function in PD model by Finkelstein et al
|
|
pivalde
|
3 |
1.3K |
9 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
3
|
1.3K
|
9
|
|
ASX - By Stock
|
ATH |
Shorts down a lot
|
|
pivalde
|
1 |
650 |
10 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
1
|
650
|
10
|
|
ASX - By Stock
|
ATH |
Mitochondrial oxidative stress associated with amyloid β aggregates
|
|
pivalde
|
0 |
349 |
7 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
0
|
349
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Presentation to Extraordinary General Meeting
|
|
pivalde
|
6 |
2.7K |
4 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
6
|
2.7K
|
4
|
|
ASX - By Stock
|
ATH |
Retina in PD by Finkelstein et al
|
|
pivalde
|
0 |
337 |
3 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
0
|
337
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Becoming a substantial holder
|
|
pivalde
|
13 |
4.0K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
13
|
4.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Becoming a substantial holder
|
|
pivalde
|
13 |
4.0K |
7 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
13
|
4.0K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Becoming a substantial holder
|
|
pivalde
|
13 |
4.0K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
13
|
4.0K
|
0
|
|